Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis

Dissegna, Denis
Sponza, Massimo
Falleti, Edmondo
Fabris, Carlo
Vit, Alessandro
Angeli, Paolo
Piano, Salvatore
Cussigh, Annarosa
Cmet, Sara
Toniutto, Pierluigi

Open link

Publication date

January 2018

DOI

10.1097/MEG.0000000000001342

Publisher

Ovid Technologies (Wolters Kluwer Health)

ISSN

0954-691X

Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) is adopted to treat refractory complications of portal hypertension, such as variceal bleeding and ascites. This study aimed to assess predictors of hepatic encephalopathy (HE) development and cumulative transplant-free survival after TIPS placement in patients with cirrhosis complicated by refractory ascites and major gastroesophageal bleeding

Extracted data

We use cookies to provide a better user experience.

Data Protection

Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis

Abstract

Extracted data

Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis

Abstract

Extracted data

Related items

Related items